National Comprehensive Cancer Network’s patient information team provides a patient and caregiver version of recently-updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.
130 cancer centers and other cancer organizations sent a letter to President Joseph R. Biden, key members of his administration, and leading state public health officials to strongly encourage prioritizing patients with cancer and survivors of cancer when administering lifesaving COVID-19 vaccines.
The National Comprehensive Cancer Network put out new guidance for COVID-19 vaccinations in people with cancer, based on available evidence plus consensus from top hematology and oncology experts with particular expertise in infectious diseases, vaccine development and delivery, and medical ethics.
AACI was invited last summer to join the Vaccine Consultation Panel (VCP) alongside other leading health and science organizations in the U.S. Through the VCP, AACI has received periodic updates on the development and distribution of COVID-19 vaccines and participated in efforts to educate the cancer center community and the general public on the importance of widespread vaccine uptake.
The Association of American Cancer Institutes (AACI) commends the U.S. Food and Drug Administration (FDA) for its swift action to grant Emergency Use Authorization (EUA) to Pfizer’s COVID-19 vaccine.
Cancer patients, especially newly diagnosed and African American patients, are significantly at risk for COVID-19 infection, hospitalization and mortality, according to a new study published in JAMA Oncology by researchers from Case Western Reserve University School of Medicine and the Case Comprehensive Cancer Center.
In a November 20 letter, the Association of American Cancer Institutes (AACI) called on the Trump administration to share vital information about its coronavirus response with President-elect Joe Biden and his transition team.
Dana-Farber Cancer Institute, one of the world’s leading centers of cancer research and treatment, and Quest Diagnostics, (NYSE: DGX), the world’s leading provider of diagnostic information services, announced the start of a new research study that provides free COVID-19 antibody testing to individuals who are at high risk of developing multiple myeloma.
Beta-blockers could potentially be used to treat COVID-19, according to a new international study by Italian and Australian scientists.
Cedars-Sinai has been awarded a five-year, $8.3 million grant by the National Cancer Institute (NCI) to study the diversity and determinants of the immune-inflammatory response to SARS-CoV-2, the virus that causes COVID-19 (coronavirus).
A new expressive writing tool allows people to put their thoughts and feelings into words to help relieve stress and anxiety. Participants are given a prompt and directed to write for 5-10 minutes, expressing their deepest thoughts and feelings. A computer analyzes keywords and tone to provide feedback.
To help better understand the impact and outcomes of COVID-19 in people undergoing cancer treatment, UCLA are participating in a NCI study with cancer centers across the country.
The GO2 Foundation together with other patient advocacy groups, has conducted a survey on the effect of COVID on lung cancer patients and recently participated in an expert panel event with Newswise. Biography :Chief Patient Officer at GO2 Foundation for…
The GO2 Foundation together with other patient advocacy groups, has conducted a survey on the effect of COVID on lung cancer patients and recently participated in an expert panel event with Newswise. “Now we see the pandemic kind of marching…
The University of Texas MD Anderson Cancer Center is committed to safely providing patient care and cancer screenings throughout the novel coronavirus (COVID-19) pandemic.
A team of researchers interviewed physicians and patients at the beginning of the COVID-19 pandemic to identify eight scenarios impacting cancer care. Using communication strategies, they created examples of language to help oncologists respond to patients empathetically.
A team of researchers at Memorial Sloan Kettering Cancer Center (MSK) reported on the epidemiology of COVID-19 illness experienced at an NCI-designated cancer center during the height of pandemic in New York City.